Yeah sure, so they raised $5M over the last 6 months, although the large majority went into the new facility and equipment, they only had $1.9M as of end of June, since then they have had trial orders of considerable amounts, of which they require buying the raw product to turn into powders. I believe over two months, fulfilling these contracts and other existing contracts, that they will have around ~$1.5M left
Its very rare for a company of $40-50M size to let their cash fall below $2M, it's just dangerous business practices and can cause bankruptcy if something like March corona market equivalent came around where raising money is exceedingly difficult - usually sub $2M cash warrants a capital raise. That is why I see one due, plus would hope for one given they can accelerate their growth phase. The only thing NZS would be thinking is VWAP, they can only issue capital at a price that is an average of the NZS stock price for the past couple weeks (they will try maintain high prices for the next couple weeks before raising imo - which explains the presentation)
Long term, it's a good thing for NZS to get capital at a high stock price, but dilution is dilution, it will likely stunt momentum if no other contract is announced.
- Forums
- ASX - By Stock
- NZS
- NZ Marine Biotech ($20M MC - High Growth Prospect)
NZ Marine Biotech ($20M MC - High Growth Prospect), page-476
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NZS (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.334M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NZS (ASX) Chart |
Day chart unavailable
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online